| 05/04/2026 3:15 PM | Serina Therapeutics (1708599) Subject Sio Capital Management, LLC (1482416) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 3:17 PM | Serina Therapeutics (1708599) Filer | Form DEFA14A | |
| 04/21/2026 4:12 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/21/2026 2:45 PM | Bailey Gregory (1329505) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 2:31 PM | Serina Therapeutics (1708599) Issuer Venkatesan Jay (1413350) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 4:12 PM | Serina Therapeutics (1708599) Filer | Form PRE 14A | |
| 03/27/2026 12:57 PM | Serina Therapeutics (1708599) Filer | Form 10-K/A | |
| 03/25/2026 4:31 PM | Serina Therapeutics (1708599) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/25/2026 3:08 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 6:24 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:07 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for SER and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Serina Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/20/2026 1:20 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:24 AM | GILL SIMBA (1180763) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:29 AM | Serina Therapeutics (1708599) Issuer Tenjarla Srini (2029985) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:35 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:20 AM | LEDGER STEVEN A (1090206) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/16/2026 11:15 PM | Serina Therapeutics (1708599) Filer | Form EFFECT | |
| 02/03/2026 11:35 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 4:19 PM | Serina Therapeutics (1708599) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/29/2026 11:54 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 11:35 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 6:17 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:03 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 11:56 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 11:27 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 10:40 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 1:04 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 6:56 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:59 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 11:48 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 3:17 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/04/2025 6:56 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 4:21 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 8:20 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 12:47 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 5:03 AM | Serina Therapeutics (1708599) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/13/2025 5:05 AM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 11:36 AM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 11:38 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 6:57 PM | Serina Therapeutics (1708599) Issuer Venkatesan Jay (1413350) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 7:02 PM | Marshall Richard Peter (2016188) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 11/10/2025 7:05 PM | Bailey Gregory (1329505) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 7:09 PM | Brannan Stephen K. (1777631) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 6:30 PM | Serina Therapeutics (1708599) Issuer WILSON KAREN J (1267490) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2025 3:40 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 2:29 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2025 5:03 AM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/29/2025 4:04 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2025 12:22 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2025 3:02 PM | Serina Therapeutics (1708599) Filer | Form DEFR14A | |
| 10/21/2025 11:24 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2025 3:48 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/14/2025 12:16 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2025 3:12 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/26/2025 11:19 AM | Serina Therapeutics (1708599) Filer | Form DEFA14A | |
| 09/26/2025 10:29 AM | Serina Therapeutics (1708599) Filer | Form DEF 14A | |
| 09/15/2025 4:06 PM | Serina Therapeutics (1708599) Filer | Form PRE 14A | |
| 09/15/2025 3:01 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2025 2:23 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2025 4:16 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 4:13 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 4:22 PM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2025 5:03 AM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2025 5:10 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2025 9:40 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2025 9:47 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2025 10:00 AM | Moreadith Randall (1301120) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:36 PM | Brannan Stephen K. (1777631) Reporting Serina Therapeutics (1708599) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 7:20 PM | Brannan Stephen K. (1777631) Reporting Serina Therapeutics (1708599) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/22/2025 3:40 PM | Serina Therapeutics (1708599) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |